Persist AI Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 9

Persist AI General Information

Description

Developer of AI-enabled cloud formulations intended to accelerate drug development and improve patient lives. The company focuses on using artificial intelligence-driven automation technologies such as automated drug release testing, high-throughput formulation screening, and method transfer and manufacturing scale-up, enabling drug manufacturers to speed up drug formulation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 890 Embarcadero Drive
  • CoLaborator Space
  • West Sacramento, CA 95605
  • United States
+1 (510)
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Other Healthcare Technology Systems
Vertical(s)
Advanced Manufacturing, LOHAS & Wellness, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 890 Embarcadero Drive
  • CoLaborator Space
  • West Sacramento, CA 95605
  • United States
+1 (510)

Persist AI Timeline

202320242025
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Persist AI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 24-Dec-2024 Completed Generating Revenue
5. Seed Round 16-Aug-2023 Completed Generating Revenue
4. Early Stage VC (Series A) Cancelled Generating Revenue
3. Accelerator/Incubator 28-Jul-2023 Completed Generating Revenue
2. Accelerator/Incubator 24-Apr-2023 $500K $4.67M Completed Generating Revenue
1. Seed Round 15-Dec-2022 $4.17M $4.17M Completed Generating Revenue
To view Persist AI’s complete valuation and funding history, request access »

Persist AI Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed-1 2,851,392 $0.000010 $1.15 $1.15 1x $1.15 16.35%
To view Persist AI’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Persist AI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of AI-enabled cloud formulations intended to accelerate drug development and improve patient lives. The compan
Drug Discovery
West Sacramento, CA
10 As of 2024

Groningen, Netherlands
 

Essen, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Persist AI Competitors (2)

One of Persist AI’s 2 competitors is InnoCore Pharmaceuticals, a Corporation company based in Groningen, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InnoCore Pharmaceuticals Corporation Groningen, Netherlands
Evonik Industries Formerly PE-Backed Essen, Germany
You’re viewing 2 of 2 competitors. Get the full list »

Persist AI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Persist AI Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Good AI Capital Venture Capital Minority
Fellows Fund Venture Capital Minority
Jovono Venture Capital Minority
Pioneer Fund Venture Capital Minority
National IT Industry Promotion Agency Government
You’re viewing 5 of 9 investors. Get the full list »

Persist AI FAQs

  • When was Persist AI founded?

    Persist AI was founded in 2022.

  • Where is Persist AI headquartered?

    Persist AI is headquartered in West Sacramento, CA.

  • What is the size of Persist AI?

    Persist AI has 10 total employees.

  • What industry is Persist AI in?

    Persist AI’s primary industry is Drug Discovery.

  • Is Persist AI a private or public company?

    Persist AI is a Private company.

  • What is Persist AI’s current revenue?

    The current revenue for Persist AI is .

  • How much funding has Persist AI raised over time?

    Persist AI has raised $8.67M.

  • Who are Persist AI’s investors?

    Good AI Capital, Fellows Fund, Jovono, Pioneer Fund, and National IT Industry Promotion Agency are 5 of 9 investors who have invested in Persist AI.

  • Who are Persist AI’s competitors?

    InnoCore Pharmaceuticals and Evonik Industries are competitors of Persist AI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »